It was great to welcome so many colleagues at the LACDR Spring Symposium! After an inspiring lecture by Dr. Avinash Patel from Dewpoint Therapeutics, nine PhD speakers from LACDR, LIC, CHDR and LUMC-KFT gave presentations on a wide range of pharma-related topics. These speakers competed for first place.…

This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…

Organisation

It was great to welcome so many people at the LACDR Spring symposium on the 4th of April 2023. The meeting started with an inspiring lecture of Dr. Mustafa Diken (Bioentech) on the evolution of mRNA vaccines. Afterwards, PhD speakers from LACDR, LIC and CHDR gave presentations on a wide range of pharma-related…

How can you ensure that your research hits the headlines? How can you bring your research output, such as PhD research or a publication, to the attention of the public?

It’s been exactly 20 years since Luris first began working with Leiden’s researchers and students to create an impact on society. To celebrate this anniversary, staff look back on their most memorable projects. Spoiler: they all had difficulty choosing one single project.

It was great to welcome so many people at the LACDR Spring symposium which was held on May 19th. After an inspiring lecture of Dr. Frederica Eduati, associate professor at the Eindhoven University of Technology, the PhD speakers impressed with their talks. The poster sessions gave a good inside in the…

A new academic year also means a (partly) new Faculty Council. What are the priorities for this year? We spoke with Chair Véronique Roos and Vice-Chair Lars Jeuken. ‘Anyone can come to us – we’re here to help.’

He had been back from Australia for less than 48 hours, but there was no sign of that. Michel Mandjes of MI had the honor of kicking off the very first Tuesday Talks: Science Insights on Tuesday. He did so with a presentation on complex networks.

Organisation

One of our PhD candidates at the LACDR, Joey Zuijdervelt, recently achieved recognition by winning the first prize in the ‘Schild-De Groen Onderzoeksprijzen’ for cancer research. His award-winning master’s thesis explored glioblastoma multiforme through an innovative orthotopic zebrafish xenograft model,…

Organisation

Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…

On the International Day of Women and Girls in Science (11 February) RISE puts the spotlight on four women in our faculty. The Researchers in Science for Equality (RISE) network is launching a junior board on this special day. Their main task? Optimise the information provision between RISE and the…

In early 2026, two new programme directors will begin their roles at FWN. Joost Broekens will take charge of the bachelor’s programme in Data Science and Artificial Intelligence (DSAI), while Sander van Kasteren will become programme director of the MSc in Life Science and Technology (LST).

Siemens recently took over the Leiden software company Culgi, founded by professor and inventor J.G.E.M. (Hans) Fraaije. We spoke to him about the algorithm that made him successful, the role of a university in our society and his ambitions at Siemens. ‘I was looking for Siemens, and they were looking…

How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…

The fastest chemical reaction in the universe takes place inside our eyes.

About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…

‘Microscopy is by far the least understood, most inefficiently operated, and the most abused of all laboratory instruments,’ reads the quote on the office wall of microscopy unit supporters Joost Willemse en Gerda Lamers. It describes exactly why the two developed the microscopy course for starting…

Smart drug carriers, uneven cosmic expansion, and solar energy storage in molecules. These are the topics of three newly awarded NWO-XS grants to researchers at the Faculty of Science.

Sander van Kasteren only noticed some small, subtle changes since he was appointed professor on 1 May. Still, he has to get used to the idea, even though he had been working towards the professorship for a few years. ‘I don't quite see myself as a professor yet.'

Cells in our bodies are often threatened by errors in our own proteins. The FLOW consortium, comprising scientists from various institutions including Leiden, is poised to meticulously map out for the first time how cells control proteins, correcting or removing faulty ones. This endeavour holds promise…

PhD candidate Joeri Schoenmakers works at the LIC and describes how his days revolve around new experiments, oxygen-free reactions and supervising students. The mix of freedom, variety and a close-knit team means he enjoys both his research and his teaching role every single day.

On 15 April, our much-beloved and highly respected former colleague Dr Hans Brussee passed away from cancer. In January 2025, Hans began experiencing neck pain. Initially, it appeared to be a herniated disc, but sadly, the diagnosis was soon revised, and his condition proved untreatable. Hans was 77…

ICT

Guiding people and helping them flourish. That's what Alexandra Blank's work is about. She has two jobs at W&N and she likes them both. ‘It is precisely because I combine these two jobs that I can do both well'.

A bacterium hiding from the immune system and picking up bits of DNA from its environment. The result: gaining new traits, such as better protection against antibiotics. Fortunately, we have not found such a damning scenario yet. However, PhD student Renée Kapteijn did find the first clues, which…